congenital urachal anomaly
ORPHA: 4357431 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| oxybutynin | Oral tablet 5mg, extended-release tablet 5mg/10mg/15mg, transdermal patch 3.9mg/day | FDA Approved, EMA Approved | 10 | 3d |
Classification & Codes
Orphanet Code
ORPHA:435743congenital urachal anomaly
| Orphanet | ORPHA:435743 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO